Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
BTW: If anyone knows how the new accounting will affect us, please comment. Thanks.
Hope so. Very quiet news-wise. We will have our first quarter reporting with new accounting method.
Hi BB,
I was just about to post that. Thanks. Good day today.
Best to you too,BB. Have a peaceful holiday eveyone.
Thanks JTFM. It's been quiet. We are due for a little noise.
The molecular biologist is advertised again. No location.
http://www.anipharmaceuticals.com/careers_positions.php
The Molecular Biologist position is listed again. Unknown location.
http://www.anipharmaceuticals.com/careers_positions.php
Catty,
None of us have a crystal ball but I suggest you listen to the conference call and read the corporate presentation if you haven't already.
Not too far away. I know you have family near there. I'm closer to Cooperstown. It's snowing again.
It's March. This stuff better melt fast! Drive safely if you venture out.
BB, Could be. This will continue to be a long term investment for me.
Best of luck everyone and take it easy shoveling all nor'easters! We got just under 3 feet!
Thanks Jeff. Always appreciate your viewpoint.
Hi Jeff, We do seem to get punished when we miss, even if it's a small miss in a great year. We do get rewarded when we beat, however. Is that because we have such a small float? Growth and catalysts in 2017.
Hi Jeff, We do seem to get punished when we miss, even if it's a small miss in a great year. We do get rewarded when we beat, however. Is that because we have such a small float? Growth and catalysts in 2017.
The only position (job) posted on the ATRS website:
http://www.antarespharma.com/employment
Director/Senior Director of Managed Markets and Trade
http://gethookedforlife.com/2017/03/ani-pharmaceuticals-baudette-expansion/
New story about the current expansion project for our Beaudette,MN plant.
A merger with Antares makes sense. Good insight! The 2 companies share much intellectual property too, including Elestrin. Both Minnesota-based.
Just read transcript. Much better than listening only.Our eemt sales are way down. Makes me wonder about ALL eemt sales...Would love to know if compounded scripts are way up.
Hi JTFM
I thought it was interesting in the CC when they talked about changing accounting methodology to align with industry peers. Do you or anyone else know why we have been using different accounting? ...or how we would have appeared on paper yesterday if the new accounting practices had been used?
Obviously disappointed with market reaction yesterday.Guidance looks good for 2017.
This was published today and I do not know anything about the source!
Intrauterine devices are not on our product list.If this is true it must be a contract.Interesting.
http://www.kten.com/story/34592919/intrauterine-devices-iuds-market-global-industry-analysis-and-opportunity-and-forecast-2017-to-2022
So by tonight we have all read that Roth has reduced us to a "buy" rating because there is a prediction that we may have lost a small market share of eemt, even though we now make a ton of other products during 2 factory shifts. I am struck by the irony that eemt is being identified as a culprit as we all await news on the transdermal product that could pretty much eliminate sales of eemt. JMO
Jeff- Did not see that. Thank you!
I get it. Remember that ANI added a second shift!
We stand exactly where we stood the last time someone asked that question: waiting for libigel announcement. The good news is that there are lots of other catalysts while we wait.
Shouldn't we be launching something?
Exciting! I'd love to be a fly on the wall when you talk to Loko! He is an amazing poster on the ATRS board. With you he may have met his match!
JTFM
Saw today's Seeking Alpha article on ATRS. Author gave you well deserved credit for Libigel research. Thanks.
JTFM, Thanks for taking the time to write the SA article.Nice job!
Hi Jeff
I believe it and I'm ready! Best to you.
We are currently selling several opioid products. For good reason, the industry is being pressured to convert to abuse deterrent products. This could be the reason for the molecular biologist position.
http://blogs.fda.gov/fdavoice/index.php/2016/10/key-facts-about-abuse-deterrent-opioids
The other day I posted an article that summarized trasdermal T research for women.
The doctor in this news piece is Nick Panay, same doctor who authored the article:
http://www.itv.com/news/2016-10-08/women-should-be-offered-testosterone-to-boost-sex-drive-doctors-suggest/
Nice find. Slim chance of coincidence!
New journal article summarizing efficacy of transdermal T research. Not easy to find!
http://www.fertstert.org/article/S0015-0282(16)62951-5/abstract#/article/S0015-0282(16)62951-5/fulltext?mobileUi=1
Conclusion
The short-term efficacy in terms of improvement of sexual function and safety of transdermal T in naturally and surgically menopausal women affected by HSDD either on or not on estrogen ± progestin HT is evident from this systematic review. The use of transdermal T is associated with an increase in androgenic adverse events such as acne but is not associated with any serious adverse events. Data on long-term safety outcomes are lacking, and further studies are needed to assess long-term outcomes such as cardiovascular and breast safety.
Beautiful message, Big B. Thank you.
A safe and happy holiday weekend to you and all board contributors.
Thanks dasgrunt. This is just a stab at an answer: page 14 shows a flow chart indicating 6 months minimum for prior approval supplement. If so, any time now.
http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM404441.pdf
Dasgrunt and Yodle, Thanks for the info!
I was not aware that there was a patent application by P&G from 2009 linking T and heart failure improvement. Obviously Biosante was aware of this when their application was filed. Still, interesting that the Intrinsa clinical trials must have yielded similar positive data.
http://www.patentsencyclopedia.com/app/20090285893
Good day today!
Could be. So many ways to make money on fear, if that's how how you operate. The power of the carefully worded PR and the short sale. The sad thing is that we have grown accustomed...
Just an excuse for any connected to the justice dept to get out before
the "overreaction." Now they can all get back in before the collective slap on the wrist. Has horrified government created a less expensive epi-pen yet? Games.